Growth Metrics

Neogen (NEOG) Cash from Investing Activities Growth (1y) (2011 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Investing Growth (1y) (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn -4,224.26%
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn 95.53%
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn 3.20%
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn -18.20%
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn -208.79%
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn -187.82%
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn -397.90%
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn -514.25%
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn -211.17%
10 Neogen 1.94 Bn 1.78 Bn 99.00 Mn 64.42%

Historic Data

Download Data 🔒
DateValue
Feb 28, 2026 64.42%
Nov 30, 2025 31.99%
Aug 31, 2025 390.31%
May 31, 2025 9.29%
Feb 28, 2025 -121.90%
Nov 30, 2024 -248.73%
Aug 31, 2024 -287.63%
May 31, 2024 -354.84%
Feb 29, 2024 -174.98%
Nov 30, 2023 -87.60%
Aug 31, 2023 -110.64%
May 31, 2023 140.21%
Feb 28, 2023 226.89%
Nov 30, 2022 336.42%
Aug 31, 2022 421.32%
May 31, 2022 46.08%
Feb 28, 2022 74.74%
Nov 30, 2021 -272.56%
Aug 31, 2021 28.90%
May 31, 2021 -159.75%
Feb 28, 2021 -41.83%
Nov 30, 2020 224.81%
Aug 31, 2020 -132.62%
May 31, 2020 83.83%
Feb 29, 2020 -110.95%
Nov 30, 2019 -16.35%
Aug 31, 2019 -102.81%
May 31, 2019 -238.69%
Feb 28, 2019 -345.83%
Nov 30, 2018 3.92%
Aug 31, 2018 81.01%
May 31, 2018 -656.57%
Feb 28, 2018 90.73%
Nov 30, 2017 -172.35%
Aug 31, 2017 -910.67%
May 31, 2017 87.30%
Feb 28, 2017 -277.44%
Nov 30, 2016 -151.86%
Aug 31, 2016 89.18%
May 31, 2016 -274.31%
Feb 29, 2016 -261.11%
Nov 30, 2015 166.80%
Aug 31, 2015 -2,642.33%
May 31, 2015 57.21%
Feb 28, 2015 64.21%
Nov 30, 2014 -87.59%
Aug 31, 2014 92.39%
May 31, 2014 -25.32%
Feb 28, 2014 -217.75%
Nov 30, 2013 15.13%
Aug 31, 2013 -41.65%
May 31, 2013 -100.87%
Feb 28, 2013 -64.95%
Nov 30, 2012 -226.17%
Aug 31, 2012 26.20%
May 31, 2012 -9.81%
Feb 29, 2012 6.55%
Nov 30, 2011 204.92%
Aug 31, 2011 -33.59%